Inhibition of protein kinase B/Akt: implications for cancer therapy
- 31 March 2002
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 93 (2-3), 243-251
- https://doi.org/10.1016/s0163-7258(02)00193-6
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Inhibition of cAMP-response Element-binding Protein Activity Decreases Protein Kinase B/Akt Expression in 3T3-L1 Adipocytes and Induces ApoptosisPublished by Elsevier BV ,2002
- Raf-MEK-Erk Cascade in Anoikis Is Controlled by Rac1 and Cdc42 via AktMolecular and Cellular Biology, 2001
- Identification of Tyrosine Phosphorylation Sites on 3-Phosphoinositide-dependent Protein Kinase-1 and Their Role in Regulating Kinase ActivityPublished by Elsevier BV ,2001
- Mammary Gland Involution Is Delayed by Activated Akt in Transgenic MiceMolecular Endocrinology, 2001
- Inhibition of integrin linked kinase (ILK) suppresses β-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC−/− human colon carcinoma cellsOncogene, 2001
- Akt Phosphorylation Site Found in Human Caspase-9 Is Absent in Mouse Caspase-9Biochemical and Biophysical Research Communications, 1999
- Induction of NF-κB by the Akt/PKB kinaseCurrent Biology, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling PathwaysScience, 1997
- Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinaseFEBS Letters, 1996